Patent Yard Sign in
Canadian application, no grantCanada

Novel polypeptides and nucleic acids encoding same

CA 2391908 A1 · Owner: Rastelli, Luca · Inventors: Spytek, Kimberley Ann; Majumder, Kumud; Quinn, Kerry E.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention provides novel isolated SERX polynucleotides and polypeptides encoded by the SERX polynucleotides. Also provided are the antibodies that immunospecifically bind to a SERX polypeptide or any derivative, variant, mutant or fragment of the SERX polypeptide polynucleotide or antibody. The invention additionally provides methods in which the SERX polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states as well as to , other uses.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 17, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 17, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 17, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 17, 2000
GrantedNo grant recorded
Term endedNovember 17, 2020
Patent numberCA 2391908 A1
Classification (IPC)C12N15/54 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedNov 17, 2000Term endedNov 17, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.